Monika Pitucha

Monika Pitucha is a Professor at the Independent Radiopharmacy Unit within the Faculty of Pharmacy at the Medical University of Lublin, Poland. She holds a PhD and DSc, with a doctoral degree awarded in 2001. Her academic and research career is deeply rooted in pharmaceutical sciences, with a focus on drug development and medicinal chemistry.

Her research interests span a broad range of topics in pharmacology and pharmacy, particularly in the design and evaluation of novel pharmaceutical agents. Key areas include:

• Medicinal chemistry of triazoles and semicarbazides
• Antitumor and anticancer drug development
• Molecular structure-activity relationships
• Apoptosis and cell cycle modulation in tumor cells
• DNA interaction studies with ligands
• Toxicological profiling of new compounds
• Antibacterial applications of heterocyclic compounds

Analysis of her recent publications reveals a consistent and focused trajectory in the design, synthesis, and biological evaluation of triazole- and semicarbazide-based compounds with dual anticancer and antimicrobial potential. Her work integrates synthetic chemistry with in vitro biological testing across cancer and bacterial cell lines, emphasizing structure optimization for enhanced efficacy and safety.

Her scientific achievements include:

• 326 publications
• 10 patents
• 1 research project
• 1 documented achievement or award

She has promoted 3 doctoral theses, indicating her role as a supervisor and mentor in training the next generation of pharmaceutical scientists. While specific grant details are not listed, her project involvement and patent output suggest successful funding acquisition and translational research impact. She is actively engaged in research collaboration, as evidenced by multi-center publications.

Monika Pitucha leads research within the Independent Radiopharmacy Unit, contributing to both academic and applied pharmaceutical sciences, with potential implications for cancer therapy and infectious disease treatment.